O-1602 [317321-41-8]

TargetMol Chemicals

O-1602 [317321-41-8]

9

317321-41-8

Chemical

Research Use Only

O-1602

99.40%

C17H22O2

258.36

O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of cystitis.O-1602 promotes hepatic steatosis through GPR55 and PI3 kinase / Akt / SREBP-1c signalling in mice.O-1602 induces, in a GPR3-independent manner, in Hep55B cells with elevated intracellular calcium.

3 years

CC1=C(C(O)=CC(O)=C1)[C@H]2[C@H](C(C)=C)CCC(C)=C2

-20°C

12352200